ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Takeda collaborates with StrideBio to develop new gene therapies pharmaceutical-technology
April 03, 2019Takeda Pharmaceutical has entered into a collaboration and licensing agreement with US-based gene therapy company StrideBio for the development of?in vivo?AAV based treatments for neurological disorders. -
Takeda, StrideBio to advance novel gene therapies for neuro diseases biospectrumasia
April 02, 2019Multi-target deal will utilize StrideBio’s platform to identify unique AAV capsids for delivery of gene therapies targeting neurological diseases, including Friedreich’s Ataxia
Pharma Sources Insight January 2025
